NCT00655304View on ClinicalTrials.gov

The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

June 30, 2011

Conditions
Acute Liver FailureHepatic EncephalopathyIntracranial Hypertension
Interventions
DEVICE

Prometheus (R) liver support dialysis

6-8 hours of dialysis

DEVICE

CVVHDF (Continuously Veno-Venous Hemodiafiltration)

6-8 hours of dialysis with the CVVHDF system PrismaFlex offered by Gambro (Sweden).

Trial Locations (1)

2100

The liverfailure unit, Department of hepatology, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT00655304 - The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure | Biotech Hunter | Biotech Hunter